XTNT
Income statement / Annual
Last year (2024), Xtant Medical Holdings, Inc.'s total revenue was $117.27 M,
an increase of 28.44% from the previous year.
In 2024, Xtant Medical Holdings, Inc.'s net income was -$16.45 M.
See Xtant Medical Holdings, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$117.27 M |
$91.30 M |
$57.97 M |
$55.26 M |
$53.34 M |
$64.68 M |
$72.20 M |
$82.61 M |
$90.00 M |
$59.35 M |
| Cost of Revenue |
$49.05 M
|
$35.84 M
|
$25.83 M
|
$22.77 M
|
$18.95 M
|
$22.17 M
|
$28.72 M
|
$32.51 M
|
$27.71 M
|
$20.26 M
|
| Gross Profit |
$68.22 M
|
$55.47 M
|
$32.14 M
|
$32.49 M
|
$34.39 M
|
$42.52 M
|
$43.49 M
|
$50.10 M
|
$62.29 M
|
$39.08 M
|
| Gross Profit Ratio |
0.58
|
0.61
|
0.55
|
0.59
|
0.64
|
0.66
|
0.6
|
0.61
|
0.69
|
0.66
|
| Research and Development Expenses |
$2.39 M
|
$1.34 M
|
$915.00 K
|
$870.00 K
|
$657.00 K
|
$932.00 K
|
$1.70 M
|
$2.44 M
|
$3.41 M
|
$2.55 M
|
| General & Administrative Expenses |
$28.69 M
|
$25.85 M
|
$15.46 M
|
$14.45 M
|
$13.50 M
|
$17.94 M
|
$13.00 M
|
$15.33 M
|
$16.03 M
|
$13.24 M
|
| Selling & Marketing Expenses |
$49.21 M
|
$38.44 M
|
$22.52 M
|
$21.03 M
|
$20.98 M
|
$25.84 M
|
$32.06 M
|
$40.51 M
|
$44.06 M
|
$28.73 M
|
| Selling, General & Administrative Expenses |
$77.91 M
|
$64.29 M
|
$37.98 M
|
$35.47 M
|
$34.49 M
|
$43.78 M
|
$45.06 M
|
$55.84 M
|
$60.09 M
|
$41.97 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$58.00 K
|
$3.00 K
|
-$74.71 K
|
-$351.91 K
|
$388.18 K
|
| Operating Expenses |
$80.29 M
|
$65.63 M
|
$38.89 M
|
$36.34 M
|
$35.14 M
|
$44.77 M
|
$50.88 M
|
$63.77 M
|
$68.44 M
|
$48.34 M
|
| Cost And Expenses |
$129.34 M
|
$101.46 M
|
$64.72 M
|
$59.12 M
|
$54.09 M
|
$66.94 M
|
$79.60 M
|
$96.28 M
|
$96.15 M
|
$68.60 M
|
| Interest Income |
$0.00
|
$149.00 K
|
$31.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$4.16 M
|
$2.94 M
|
$1.69 M
|
$995.00 K
|
$5.98 M
|
$5.77 M
|
$10.15 M
|
$14.70 M
|
$12.26 M
|
$7.73 M
|
| Depreciation & Amortization |
$4.22 M
|
$3.17 M
|
$1.30 M
|
$1.34 M
|
$2.08 M
|
$3.20 M
|
$5.74 M
|
$8.39 M
|
$7.24 M
|
$4.89 M
|
| EBITDA |
-$7.88 M |
$5.08 M |
-$5.43 M |
-$2.51 M |
$1.33 M |
$850.00 K |
-$54.22 M |
-$29.31 M |
$61.43 K |
-$7.09 M |
| EBITDA Ratio |
-0.07
|
0.06
|
-0.09
|
-0.05
|
0.02
|
0.01
|
-0.75
|
-0.35
|
0
|
-0.12
|
| Operating Income Ratio |
-0.1
|
-0.11
|
-0.12
|
-0.07
|
-0.01
|
-0.04
|
-0.83
|
-0.46
|
-0.08
|
-0.2
|
| Total Other Income/Expenses Net |
-$4.19 M
|
$9.12 M
|
-$1.66 M
|
-$995.00 K
|
-$5.98 M
|
-$5.87 M
|
-$10.02 M
|
-$14.58 M
|
-$11.90 M
|
-$7.63 M
|
| Income Before Tax |
-$16.26 M
|
-$1.04 M
|
-$8.42 M
|
-$4.85 M
|
-$6.73 M
|
-$8.12 M
|
-$70.10 M
|
-$52.41 M
|
-$19.44 M
|
-$19.71 M
|
| Income Before Tax Ratio |
-0.14
|
-0.01
|
-0.15
|
-0.09
|
-0.13
|
-0.13
|
-0.97
|
-0.63
|
-0.22
|
-0.33
|
| Income Tax Expense |
$187.00 K
|
-$1.70 M
|
$69.00 K
|
$0.00
|
$296.00 K
|
$98.00 K
|
$124.00 K
|
$0.00
|
$50.36 K
|
-$17.54 M
|
| Net Income |
-$16.45 M
|
$660.00 K
|
-$8.49 M
|
-$4.85 M
|
-$7.02 M
|
-$8.22 M
|
-$70.10 M
|
-$52.41 M
|
-$19.49 M
|
-$2.17 M
|
| Net Income Ratio |
-0.14
|
0.01
|
-0.15
|
-0.09
|
-0.13
|
-0.13
|
-0.97
|
-0.63
|
-0.22
|
-0.04
|
| EPS |
-0.12 |
0.0055 |
-0.0902 |
-0.0567 |
-0.25 |
-0.62 |
-5.97 |
-34.76 |
-18.46 |
-2.62 |
| EPS Diluted |
-0.12 |
0.0052 |
-0.0902 |
-0.0567 |
-0.25 |
-0.62 |
-5.93 |
-34.51 |
-18.32 |
-2.62 |
| Weighted Average Shares Out |
$133.67 M
|
$119.09 M
|
$94.09 M
|
$85.46 M
|
$28.50 M
|
$13.16 M
|
$11.74 M
|
$1.51 M
|
$1.06 M
|
$829.71 K
|
| Weighted Average Shares Out Diluted |
$133.67 M
|
$126.79 M
|
$94.09 M
|
$85.46 M
|
$28.50 M
|
$13.16 M
|
$11.83 M
|
$1.52 M
|
$1.06 M
|
$829.71 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
